Lancashire and South Cumbria
Formulary
2 Cardiovascular system
02-03-02 Supraventricular arrhythmias
Dronedarone
Formulary
Tablets 400mg
On advice of cardiology only
LSCMMG Shared Care Protocol: Dronedarone for patients within adult services
MHRA: Dronedarone (Multaq▼): cardiovascular, hepatic and pulmonary adverse events – new restrictions and monitoring requirements
NICE TA197: Dronedarone for the treatment of non-permanent atrial fibrillation
Adenosine
Formulary
Injection 6mg/2mL
Links
Enoxaparin for Treatment of Venous Thromboembolism **FOR USE IN THE BLACKPOOL REGION ONLY**
Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**
Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY*
LSC Hypertension in Adults: Diagnosis and Management
LSC Statin Intolerance Pathway
LSCMMG Shared Care Protocol: Amiodarone for patients within adult services
LSCMMG Shared Care Protocol: Amiodarone for patients within adult services
LSCMMG Shared Care Protocol: Dronedarone for patients within adult services
LSCMMG: Atrial Fibrillation Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease
LSCMMG: Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia: Position Statement
LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
LSCMMG: Mexiletine NMR
MHRA Drug Safety Update March 2022: Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision
MHRA Drug Safety Update March 2022: Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision
MHRA Drug Safety Update March 2022: Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision
MHRA: Dronedarone (Multaq▼): cardiovascular, hepatic and pulmonary adverse events – new restrictions and monitoring requirements
NICE NG106: Chronic heart failure in adults: diagnosis and management
NICE NG136: Hypertension in adults: diagnosis and management
NICE NG185: Acute Coronary Syndromes
NICE NG187: Acute heart failure: diagnosis and management
NICE NG196: Atrial fibrillation: diagnosis and management
NICE NG203: Chronic kidney disease: assessment and management
NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
NICE TA197: Dronedarone for the treatment of non-permanent atrial fibrillation
NICE TA675: Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)
Policy and procedure for prophylaxis against, and treatment of, VTE in adult patients **FOR USE IN THE CENTRAL LANCS REGION ONLY**
Prevention of VTE in Medical Surgical Patients (16 years +) and those requiring lower limb plaster casts/immobilisations **FOR USE IN THE BLACKPOOL REGION ONLY**
Renal: Enhanced Supportive Kidney Care Guideline
Key
Full Site